Ursula Ungaro
Director at Longeveron.
Raised on Longeveron filings
$15.9M
of $33.5M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 9
- Last filing
- Mar 25, 2026
Company
Bone marrow cell therapy for heart defects and frailty
- Investors
- 7
- Still open
- $17.6M
Longeveron filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 25, 2026 | Equity | $15.9M/ $33.5M | Form D |
- EquityFiled Mar 25, 2026Form D$15.9M/ $33.5M
Works with
Lisa A. LocklearChief Financial Officer, Form D signerForm D signerGeorge Paletta, Jr.DirectorJoshua M. HareExecutive Officer, DirectorRoger Joseph HajjarDirectorStephen H. WillardExecutive OfficerDevin BlassExecutive OfficerNataliya AgafonovaExecutive OfficerPaul LehrExecutive OfficerRock SofferDirector
